{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:19:49Z","timestamp":1767979189535,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.urology.2017.05.016","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T16:35:54Z","timestamp":1495125354000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome"],"prefix":"10.1016","volume":"107","author":[{"given":"Iryna M.","family":"Crescenze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Tucky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtenay","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Shoskes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.05.016_bib0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2011.03.132","article-title":"Prevalence of symptoms of bladder pain syndrome\/interstitial cystitis among adult females in the United States","volume":"186","author":"Berry","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2012.08.088","article-title":"The prevalence and overlap of interstitial cystitis\/bladder pain syndrome and chronic prostatitis\/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study","volume":"189","author":"Suskind","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0020","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0022-5347(01)66137-8","article-title":"Cyclosporine in severe interstitial cystitis","volume":"155","author":"Forsell","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0025","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1097\/01.ju.0000125139.91203.7a","article-title":"Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A","volume":"171","author":"Sairanen","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0030","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.juro.2012.06.023","article-title":"Cyclosporine A for refractory interstitial cystitis\/bladder pain syndrome: experience of 3 tertiary centers","volume":"188","author":"Forrest","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0035","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1097\/01.ju.0000181808.45786.84","article-title":"Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study","volume":"174","author":"Sairanen","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.juro.2009.02.122","article-title":"Clinical phenotyping of women with interstitial cystitis\/painful bladder syndrome: a key to classification and potentially improved management","volume":"182","author":"Nickel","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2008.42","article-title":"Clinical phenotyping in chronic prostatitis\/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes","volume":"12","author":"Shoskes","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2017.05.016_bib0050","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","article-title":"AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"185","author":"Hanno","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0055","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1097\/01.TP.0000068868.01424.61","article-title":"Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients","volume":"75","author":"Cole","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.urology.2017.05.016_bib0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-6143.2002.020206.x","article-title":"Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation","volume":"2","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.urology.2017.05.016_bib0065","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1097\/01.ASN.0000088721.98173.4B","article-title":"A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease","volume":"14","author":"Lin","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.urology.2017.05.016_bib0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00041552-199511000-00010","article-title":"Iothalamate clearance and its use in large-scale clinical trials","volume":"4","author":"Hall","year":"1995","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.urology.2017.05.016_bib0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/nau.20687","article-title":"Status of international consensus on interstitial cystitis\/bladder pain syndrome\/painful bladder syndrome: 2008 snapshot","volume":"28","author":"Hanno","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.05.016_bib0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2006.08.1106","article-title":"Chronic prostatitis\/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities","volume":"69","author":"Forrest","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.05.016_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0090-4295(01)01126-8","article-title":"Psychometric validation of the O'leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium","volume":"57","author":"Lubeck","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.05.016_bib0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/01.ju.0000152672.83393.61","article-title":"Correlation between 2 interstitial cystitis symptom instruments","volume":"173","author":"Sirinian","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","article-title":"The interstitial cystitis symptom index and problem index","volume":"49","author":"O'Leary","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.05.016_bib0100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.healun.2003.05.002","article-title":"Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral)","volume":"24","author":"Jaksch","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.urology.2017.05.016_bib0105","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.transproceed.2009.06.155","article-title":"Correlation of C0 and C2 levels with cyclosporine side effects in kidney transplantation","volume":"41","author":"Rodrigo","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.urology.2017.05.016_bib0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1399-3046.2008.00968.x","article-title":"Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough","volume":"13","author":"Schrauder","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.urology.2017.05.016_bib0115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","article-title":"A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis","volume":"170","author":"Sant","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.05.016_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-5347(17)43863-8","article-title":"Chronic interstitial cystitis: a heterogeneous syndrome","volume":"137","author":"Fall","year":"1987","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517305095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517305095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T18:23:38Z","timestamp":1535826218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429517305095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":23,"alternative-id":["S0090429517305095"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.05.016","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}